Chitosan as an environment friendly biomaterial–a review on recent modifications and applications

PS Bakshi, D Selvakumar, K Kadirvelu… - International journal of …, 2020 - Elsevier
Amongst the natural polymers, chitin is the second most abundant, present mainly in fungi
and exoskeleton of crustaceans. It forms a major part of the seafood waste as compiled and …

Chitosan-based (Nano) materials for novel biomedical applications

G Kravanja, M Primožič, Ž Knez, M Leitgeb - Molecules, 2019 - mdpi.com
Chitosan-based nanomaterials have attracted significant attention in the biomedical field
because of their unique biodegradable, biocompatible, non-toxic, and antimicrobial nature …

Progress in brain targeting drug delivery system by nasal route

AR Khan, M Liu, MW Khan, G Zhai - Journal of Controlled Release, 2017 - Elsevier
The blood–brain barrier (BBB) restricts the transport of potential therapeutic moieties to the
brain. Direct targeting the brain via olfactory and trigeminal neural pathways by passing the …

Rational design of nanocarriers for intracellular protein delivery

X Qin, C Yu, J Wei, L Li, C Zhang, Q Wu… - Advanced …, 2019 - Wiley Online Library
Protein/antibody therapeutics have exhibited the advantages of high specificity and activity
even at an extremely low concentration compared to small molecule drugs. However, they …

Nanoemulsions for “nose-to-brain” drug delivery

MC Bonferoni, S Rossi, G Sandri, F Ferrari, E Gavini… - Pharmaceutics, 2019 - mdpi.com
The blood–brain barrier (BBB) plays a fundamental role in protecting the brain from toxic
substances and therefore also controls and restricts the entry of therapeutic agents. The …

Potential of chitosan and its derivatives for biomedical applications in the central nervous system

DD Ojeda-Hernández, AA Canales-Aguirre… - … in Bioengineering and …, 2020 - frontiersin.org
It is well known that the central nervous system (CNS) has a limited regenerative capacity
and that many therapeutic molecules cannot cross the blood brain barrier (BBB). The use of …

[HTML][HTML] Recent progress of lipid nanoparticles-based lipophilic drug delivery: focus on surface modifications

Y Seo, H Lim, H Park, J Yu, J An, HY Yoo, T Lee - Pharmaceutics, 2023 - mdpi.com
Numerous drugs have emerged to treat various diseases, such as COVID-19, cancer, and
protect human health. Approximately 40% of them are lipophilic and are used for treating …

Polymeric nanoparticles for nasal drug delivery to the brain: relevance to Alzheimer's disease

N Rabiee, S Ahmadi, R Afshari, S Khalaji… - Advanced …, 2021 - Wiley Online Library
Currently, Alzheimer's disease (AD) accounts for more than half of all dementia cases.
Although genetics, age, and environmental factors affect the disease, the cause of AD is not …

Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer's therapy

G Rassu, E Soddu, AM Posadino, G Pintus… - Colloids and Surfaces B …, 2017 - Elsevier
We designed a delivery system to obtain an efficient and optimal nose-to-brain transport of
BACE1 siRNA, potentially useful in the treatment of Alzheimer's disease. We selected a cell …

Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis

C Costa, JN Moreira, MH Amaral, JMS Lobo… - Journal of Controlled …, 2019 - Elsevier
Epileptic seizures and anxiety crisis are severe conditions that require fast and effective
treatment, targeting the brain. Current emergency antiepiletics and anxiolytics have limited …